Article ; Online: HDL as a Treatment Target: Should We Abandon This Idea?
Current atherosclerosis reports
2023 Volume 25, Issue 12, Page(s) 1093–1099
Abstract: Purpose of review: High-density lipoproteins (HDL) have long been regarded as an antiatherogenic lipoprotein species by virtue of their role in reverse cholesterol transport (RCT), as well as their established anti-inflammatory and antioxidant ... ...
Abstract | Purpose of review: High-density lipoproteins (HDL) have long been regarded as an antiatherogenic lipoprotein species by virtue of their role in reverse cholesterol transport (RCT), as well as their established anti-inflammatory and antioxidant properties. For decades, HDL have been an extremely appealing therapeutic target to combat atherosclerotic cardiovascular diseases (ASCVD). Recent findings: Unfortunately, neither increasing HDL with drugs nor direct infusions of reconstituted HDL have convincedly proven to be positive strategies for cardiovascular health, raising the question of whether we should abandon the idea of considering HDL as a treatment target. The results of two large clinical trials, one testing the latest CETP inhibitor Obicetrapib and the other testing the infusion of patients post-acute coronary events with reconstituted HDL, are still awaited. If they prove negative, these trials will seal the fate of HDL as a direct therapeutic target. However, using HDL as a therapeutic agent still holds promise if we manage to optimize their beneficial properties for not only ASCVD but also outside the cardiovascular field. |
---|---|
MeSH term(s) | Humans ; Lipoproteins, HDL ; Cholesterol, HDL/metabolism ; Atherosclerosis/drug therapy ; Biological Transport ; Cardiovascular Diseases/prevention & control ; Cardiovascular Diseases/drug therapy |
Chemical Substances | Lipoproteins, HDL ; Cholesterol, HDL |
Language | English |
Publishing date | 2023-12-05 |
Publishing country | United States |
Document type | Journal Article ; Review |
ZDB-ID | 2057369-8 |
ISSN | 1534-6242 ; 1523-3804 |
ISSN (online) | 1534-6242 |
ISSN | 1523-3804 |
DOI | 10.1007/s11883-023-01176-1 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 5534: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.